By: On: novembre 25, 2013 In: Non classé Comments: 0

canada goose A drug derived from marijuana has triggered the first federal shift on cannabis in half a century, and experts predict an avalanche effect Erin Brodwin Sep. 27, 2018, 10:56 AM Shutterstock The nation’s top drug regulator has officially changed how it regulates CBD, a marijuana compound that’s in a new epilepsy drug called Epidiolex. This is the first time in 46 years that the Drug Enforcement Administration has shifted its stance on cannabis. The DEA’s move comes after Epidiolex was greenlighted by another government regulator at the end of June. Experts say the approval will galvanize research into other marijuana-based drugs. A new drug derived from marijuana has led to a landmark change in the US government’s stance on cannabis. After being greenlighted as the first federally approved cannabis-based medication at the end of June, the drug has triggered the nation’s top drug enforcer to change how it regulates marijuana. It’s the first time in 46 years that the agency has shifted its stance on a marijuana compound. The drug, Epidiolex, is designed to treat two rare forms of childhood epilepsy using cannabidiol, or CBD, the compound in marijuana not responsible for a high. The latest move means people can now access the drug with a doctor’s prescription

Trackback URL:

Leave reply:

Votre adresse de messagerie ne sera pas publiée. Les champs obligatoires sont indiqués avec *